The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemostatic Agents and Tissue Sealants Market Research Report 2025
Synopsis
Hemostats and sealants are medical devices used to cease bleeding and hemorrhage caused by injuries and surgical procedures. The market is expected to witness lucrative growth over the next seven years owing to an increase in demand supported by the rising surgery volumes.
The global Hemostatic Agents and Tissue Sealants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Agents and Tissue Sealants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Agents and Tissue Sealants.
Report Scope
The Hemostatic Agents and Tissue Sealants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic Agents and Tissue Sealants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Agents and Tissue Sealants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical
Segment by Type
Hemostasis Agents
Tissue Sealing Agents
Segment by Application
Minimally Invasive Surgery
General Surgery
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic Agents and Tissue Sealants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic Agents and Tissue Sealants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hemostats and sealants are medical devices used to cease bleeding and hemorrhage caused by injuries and surgical procedures. The market is expected to witness lucrative growth over the next seven years owing to an increase in demand supported by the rising surgery volumes.
The global Hemostatic Agents and Tissue Sealants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Agents and Tissue Sealants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Agents and Tissue Sealants.
Report Scope
The Hemostatic Agents and Tissue Sealants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic Agents and Tissue Sealants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Agents and Tissue Sealants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical
Segment by Type
Hemostasis Agents
Tissue Sealing Agents
Segment by Application
Minimally Invasive Surgery
General Surgery
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic Agents and Tissue Sealants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic Agents and Tissue Sealants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hemostatic Agents and Tissue Sealants Market Overview
1.1 Product Overview and Scope of Hemostatic Agents and Tissue Sealants
1.2 Hemostatic Agents and Tissue Sealants Segment by Type
1.2.1 Global Hemostatic Agents and Tissue Sealants Market Value Comparison by Type (2024-2030)
1.2.2 Hemostasis Agents
1.2.3 Tissue Sealing Agents
1.3 Hemostatic Agents and Tissue Sealants Segment by Application
1.3.1 Global Hemostatic Agents and Tissue Sealants Market Value by Application: (2024-2030)
1.3.2 Minimally Invasive Surgery
1.3.3 General Surgery
1.3.4 Others
1.4 Global Hemostatic Agents and Tissue Sealants Market Size Estimates and Forecasts
1.4.1 Global Hemostatic Agents and Tissue Sealants Revenue 2019-2030
1.4.2 Global Hemostatic Agents and Tissue Sealants Sales 2019-2030
1.4.3 Global Hemostatic Agents and Tissue Sealants Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostatic Agents and Tissue Sealants Market Competition by Manufacturers
2.1 Global Hemostatic Agents and Tissue Sealants Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostatic Agents and Tissue Sealants Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostatic Agents and Tissue Sealants Average Price by Manufacturers (2019-2024)
2.4 Global Hemostatic Agents and Tissue Sealants Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostatic Agents and Tissue Sealants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostatic Agents and Tissue Sealants, Product Type & Application
2.7 Hemostatic Agents and Tissue Sealants Market Competitive Situation and Trends
2.7.1 Hemostatic Agents and Tissue Sealants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostatic Agents and Tissue Sealants Players Market Share by Revenue
2.7.3 Global Hemostatic Agents and Tissue Sealants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostatic Agents and Tissue Sealants Retrospective Market Scenario by Region
3.1 Global Hemostatic Agents and Tissue Sealants Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostatic Agents and Tissue Sealants Global Hemostatic Agents and Tissue Sealants Sales by Region: 2019-2030
3.2.1 Global Hemostatic Agents and Tissue Sealants Sales by Region: 2019-2024
3.2.2 Global Hemostatic Agents and Tissue Sealants Sales by Region: 2025-2030
3.3 Global Hemostatic Agents and Tissue Sealants Global Hemostatic Agents and Tissue Sealants Revenue by Region: 2019-2030
3.3.1 Global Hemostatic Agents and Tissue Sealants Revenue by Region: 2019-2024
3.3.2 Global Hemostatic Agents and Tissue Sealants Revenue by Region: 2025-2030
3.4 North America Hemostatic Agents and Tissue Sealants Market Facts & Figures by Country
3.4.1 North America Hemostatic Agents and Tissue Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostatic Agents and Tissue Sealants Sales by Country (2019-2030)
3.4.3 North America Hemostatic Agents and Tissue Sealants Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hemostatic Agents and Tissue Sealants Market Facts & Figures by Country
3.5.1 Europe Hemostatic Agents and Tissue Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostatic Agents and Tissue Sealants Sales by Country (2019-2030)
3.5.3 Europe Hemostatic Agents and Tissue Sealants Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic Agents and Tissue Sealants Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostatic Agents and Tissue Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostatic Agents and Tissue Sealants Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostatic Agents and Tissue Sealants Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostatic Agents and Tissue Sealants Market Facts & Figures by Country
3.7.1 Latin America Hemostatic Agents and Tissue Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostatic Agents and Tissue Sealants Sales by Country (2019-2030)
3.7.3 Latin America Hemostatic Agents and Tissue Sealants Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic Agents and Tissue Sealants Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic Agents and Tissue Sealants Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostatic Agents and Tissue Sealants Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostatic Agents and Tissue Sealants Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostatic Agents and Tissue Sealants Sales by Type (2019-2030)
4.1.1 Global Hemostatic Agents and Tissue Sealants Sales by Type (2019-2024)
4.1.2 Global Hemostatic Agents and Tissue Sealants Sales by Type (2025-2030)
4.1.3 Global Hemostatic Agents and Tissue Sealants Sales Market Share by Type (2019-2030)
4.2 Global Hemostatic Agents and Tissue Sealants Revenue by Type (2019-2030)
4.2.1 Global Hemostatic Agents and Tissue Sealants Revenue by Type (2019-2024)
4.2.2 Global Hemostatic Agents and Tissue Sealants Revenue by Type (2025-2030)
4.2.3 Global Hemostatic Agents and Tissue Sealants Revenue Market Share by Type (2019-2030)
4.3 Global Hemostatic Agents and Tissue Sealants Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostatic Agents and Tissue Sealants Sales by Application (2019-2030)
5.1.1 Global Hemostatic Agents and Tissue Sealants Sales by Application (2019-2024)
5.1.2 Global Hemostatic Agents and Tissue Sealants Sales by Application (2025-2030)
5.1.3 Global Hemostatic Agents and Tissue Sealants Sales Market Share by Application (2019-2030)
5.2 Global Hemostatic Agents and Tissue Sealants Revenue by Application (2019-2030)
5.2.1 Global Hemostatic Agents and Tissue Sealants Revenue by Application (2019-2024)
5.2.2 Global Hemostatic Agents and Tissue Sealants Revenue by Application (2025-2030)
5.2.3 Global Hemostatic Agents and Tissue Sealants Revenue Market Share by Application (2019-2030)
5.3 Global Hemostatic Agents and Tissue Sealants Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Hemostatic Agents and Tissue Sealants Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Hemostatic Agents and Tissue Sealants Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 C R Bard
6.3.1 C R Bard Corporation Information
6.3.2 C R Bard Description and Business Overview
6.3.3 C R Bard Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 C R Bard Hemostatic Agents and Tissue Sealants Product Portfolio
6.3.5 C R Bard Recent Developments/Updates
6.4 B Braun
6.4.1 B Braun Corporation Information
6.4.2 B Braun Description and Business Overview
6.4.3 B Braun Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B Braun Hemostatic Agents and Tissue Sealants Product Portfolio
6.4.5 B Braun Recent Developments/Updates
6.5 Gelita
6.5.1 Gelita Corporation Information
6.5.2 Gelita Description and Business Overview
6.5.3 Gelita Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Gelita Hemostatic Agents and Tissue Sealants Product Portfolio
6.5.5 Gelita Recent Developments/Updates
6.6 Integra Life Sciences
6.6.1 Integra Life Sciences Corporation Information
6.6.2 Integra Life Sciences Description and Business Overview
6.6.3 Integra Life Sciences Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Integra Life Sciences Hemostatic Agents and Tissue Sealants Product Portfolio
6.6.5 Integra Life Sciences Recent Developments/Updates
6.7 Advance Medical Solution
6.6.1 Advance Medical Solution Corporation Information
6.6.2 Advance Medical Solution Description and Business Overview
6.6.3 Advance Medical Solution Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Advance Medical Solution Hemostatic Agents and Tissue Sealants Product Portfolio
6.7.5 Advance Medical Solution Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Hemostatic Agents and Tissue Sealants Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 CSL Behring
6.9.1 CSL Behring Corporation Information
6.9.2 CSL Behring Description and Business Overview
6.9.3 CSL Behring Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSL Behring Hemostatic Agents and Tissue Sealants Product Portfolio
6.9.5 CSL Behring Recent Developments/Updates
6.10 CryoLife
6.10.1 CryoLife Corporation Information
6.10.2 CryoLife Description and Business Overview
6.10.3 CryoLife Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CryoLife Hemostatic Agents and Tissue Sealants Product Portfolio
6.10.5 CryoLife Recent Developments/Updates
6.11 Zimmer Biomet
6.11.1 Zimmer Biomet Corporation Information
6.11.2 Zimmer Biomet Hemostatic Agents and Tissue Sealants Description and Business Overview
6.11.3 Zimmer Biomet Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zimmer Biomet Hemostatic Agents and Tissue Sealants Product Portfolio
6.11.5 Zimmer Biomet Recent Developments/Updates
6.12 Ferrosan Medical Devices
6.12.1 Ferrosan Medical Devices Corporation Information
6.12.2 Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Description and Business Overview
6.12.3 Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Product Portfolio
6.12.5 Ferrosan Medical Devices Recent Developments/Updates
6.13 Medtronic
6.13.1 Medtronic Corporation Information
6.13.2 Medtronic Hemostatic Agents and Tissue Sealants Description and Business Overview
6.13.3 Medtronic Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Medtronic Hemostatic Agents and Tissue Sealants Product Portfolio
6.13.5 Medtronic Recent Developments/Updates
6.14 Smith & Nephew
6.14.1 Smith & Nephew Corporation Information
6.14.2 Smith & Nephew Hemostatic Agents and Tissue Sealants Description and Business Overview
6.14.3 Smith & Nephew Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Smith & Nephew Hemostatic Agents and Tissue Sealants Product Portfolio
6.14.5 Smith & Nephew Recent Developments/Updates
6.15 Z-Medica
6.15.1 Z-Medica Corporation Information
6.15.2 Z-Medica Hemostatic Agents and Tissue Sealants Description and Business Overview
6.15.3 Z-Medica Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Z-Medica Hemostatic Agents and Tissue Sealants Product Portfolio
6.15.5 Z-Medica Recent Developments/Updates
6.16 Cohera Medical
6.16.1 Cohera Medical Corporation Information
6.16.2 Cohera Medical Hemostatic Agents and Tissue Sealants Description and Business Overview
6.16.3 Cohera Medical Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Cohera Medical Hemostatic Agents and Tissue Sealants Product Portfolio
6.16.5 Cohera Medical Recent Developments/Updates
6.17 Marine Polymer
6.17.1 Marine Polymer Corporation Information
6.17.2 Marine Polymer Hemostatic Agents and Tissue Sealants Description and Business Overview
6.17.3 Marine Polymer Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Marine Polymer Hemostatic Agents and Tissue Sealants Product Portfolio
6.17.5 Marine Polymer Recent Developments/Updates
6.18 Equimedical
6.18.1 Equimedical Corporation Information
6.18.2 Equimedical Hemostatic Agents and Tissue Sealants Description and Business Overview
6.18.3 Equimedical Hemostatic Agents and Tissue Sealants Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Equimedical Hemostatic Agents and Tissue Sealants Product Portfolio
6.18.5 Equimedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic Agents and Tissue Sealants Industry Chain Analysis
7.2 Hemostatic Agents and Tissue Sealants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic Agents and Tissue Sealants Production Mode & Process
7.4 Hemostatic Agents and Tissue Sealants Sales and Marketing
7.4.1 Hemostatic Agents and Tissue Sealants Sales Channels
7.4.2 Hemostatic Agents and Tissue Sealants Distributors
7.5 Hemostatic Agents and Tissue Sealants Customers
8 Hemostatic Agents and Tissue Sealants Market Dynamics
8.1 Hemostatic Agents and Tissue Sealants Industry Trends
8.2 Hemostatic Agents and Tissue Sealants Market Drivers
8.3 Hemostatic Agents and Tissue Sealants Market Challenges
8.4 Hemostatic Agents and Tissue Sealants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Hemostatic Agents and Tissue Sealants Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hemostatic Agents and Tissue Sealants Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hemostatic Agents and Tissue Sealants Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hemostatic Agents and Tissue Sealants Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Hemostatic Agents and Tissue Sealants Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hemostatic Agents and Tissue Sealants Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hemostatic Agents and Tissue Sealants Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hemostatic Agents and Tissue Sealants Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hemostatic Agents and Tissue Sealants, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hemostatic Agents and Tissue Sealants, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hemostatic Agents and Tissue Sealants, Product Type & Application
Table 12. Global Key Manufacturers of Hemostatic Agents and Tissue Sealants, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hemostatic Agents and Tissue Sealants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Agents and Tissue Sealants as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemostatic Agents and Tissue Sealants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hemostatic Agents and Tissue Sealants Sales by Region (2019-2024) & (K Units)
Table 18. Global Hemostatic Agents and Tissue Sealants Sales Market Share by Region (2019-2024)
Table 19. Global Hemostatic Agents and Tissue Sealants Sales by Region (2025-2030) & (K Units)
Table 20. Global Hemostatic Agents and Tissue Sealants Sales Market Share by Region (2025-2030)
Table 21. Global Hemostatic Agents and Tissue Sealants Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hemostatic Agents and Tissue Sealants Revenue Market Share by Region (2019-2024)
Table 23. Global Hemostatic Agents and Tissue Sealants Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hemostatic Agents and Tissue Sealants Revenue Market Share by Region (2025-2030)
Table 25. North America Hemostatic Agents and Tissue Sealants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hemostatic Agents and Tissue Sealants Sales by Country (2019-2024) & (K Units)
Table 27. North America Hemostatic Agents and Tissue Sealants Sales by Country (2025-2030) & (K Units)
Table 28. North America Hemostatic Agents and Tissue Sealants Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hemostatic Agents and Tissue Sealants Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hemostatic Agents and Tissue Sealants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hemostatic Agents and Tissue Sealants Sales by Country (2019-2024) & (K Units)
Table 32. Europe Hemostatic Agents and Tissue Sealants Sales by Country (2025-2030) & (K Units)
Table 33. Europe Hemostatic Agents and Tissue Sealants Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hemostatic Agents and Tissue Sealants Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hemostatic Agents and Tissue Sealants Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hemostatic Agents and Tissue Sealants Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Hemostatic Agents and Tissue Sealants Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Hemostatic Agents and Tissue Sealants Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hemostatic Agents and Tissue Sealants Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hemostatic Agents and Tissue Sealants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hemostatic Agents and Tissue Sealants Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Hemostatic Agents and Tissue Sealants Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Hemostatic Agents and Tissue Sealants Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hemostatic Agents and Tissue Sealants Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hemostatic Agents and Tissue Sealants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hemostatic Agents and Tissue Sealants Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Hemostatic Agents and Tissue Sealants Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Hemostatic Agents and Tissue Sealants Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hemostatic Agents and Tissue Sealants Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hemostatic Agents and Tissue Sealants Sales (K Units) by Type (2019-2024)
Table 51. Global Hemostatic Agents and Tissue Sealants Sales (K Units) by Type (2025-2030)
Table 52. Global Hemostatic Agents and Tissue Sealants Sales Market Share by Type (2019-2024)
Table 53. Global Hemostatic Agents and Tissue Sealants Sales Market Share by Type (2025-2030)
Table 54. Global Hemostatic Agents and Tissue Sealants Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hemostatic Agents and Tissue Sealants Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hemostatic Agents and Tissue Sealants Revenue Market Share by Type (2019-2024)
Table 57. Global Hemostatic Agents and Tissue Sealants Revenue Market Share by Type (2025-2030)
Table 58. Global Hemostatic Agents and Tissue Sealants Price (US$/Unit) by Type (2019-2024)
Table 59. Global Hemostatic Agents and Tissue Sealants Price (US$/Unit) by Type (2025-2030)
Table 60. Global Hemostatic Agents and Tissue Sealants Sales (K Units) by Application (2019-2024)
Table 61. Global Hemostatic Agents and Tissue Sealants Sales (K Units) by Application (2025-2030)
Table 62. Global Hemostatic Agents and Tissue Sealants Sales Market Share by Application (2019-2024)
Table 63. Global Hemostatic Agents and Tissue Sealants Sales Market Share by Application (2025-2030)
Table 64. Global Hemostatic Agents and Tissue Sealants Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hemostatic Agents and Tissue Sealants Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hemostatic Agents and Tissue Sealants Revenue Market Share by Application (2019-2024)
Table 67. Global Hemostatic Agents and Tissue Sealants Revenue Market Share by Application (2025-2030)
Table 68. Global Hemostatic Agents and Tissue Sealants Price (US$/Unit) by Application (2019-2024)
Table 69. Global Hemostatic Agents and Tissue Sealants Price (US$/Unit) by Application (2025-2030)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson Hemostatic Agents and Tissue Sealants Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Baxter Hemostatic Agents and Tissue Sealants Product
Table 79. Baxter Recent Developments/Updates
Table 80. C R Bard Corporation Information
Table 81. C R Bard Description and Business Overview
Table 82. C R Bard Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. C R Bard Hemostatic Agents and Tissue Sealants Product
Table 84. C R Bard Recent Developments/Updates
Table 85. B Braun Corporation Information
Table 86. B Braun Description and Business Overview
Table 87. B Braun Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. B Braun Hemostatic Agents and Tissue Sealants Product
Table 89. B Braun Recent Developments/Updates
Table 90. Gelita Corporation Information
Table 91. Gelita Description and Business Overview
Table 92. Gelita Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Gelita Hemostatic Agents and Tissue Sealants Product
Table 94. Gelita Recent Developments/Updates
Table 95. Integra Life Sciences Corporation Information
Table 96. Integra Life Sciences Description and Business Overview
Table 97. Integra Life Sciences Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Integra Life Sciences Hemostatic Agents and Tissue Sealants Product
Table 99. Integra Life Sciences Recent Developments/Updates
Table 100. Advance Medical Solution Corporation Information
Table 101. Advance Medical Solution Description and Business Overview
Table 102. Advance Medical Solution Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Advance Medical Solution Hemostatic Agents and Tissue Sealants Product
Table 104. Advance Medical Solution Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Pfizer Hemostatic Agents and Tissue Sealants Product
Table 109. Pfizer Recent Developments/Updates
Table 110. CSL Behring Corporation Information
Table 111. CSL Behring Description and Business Overview
Table 112. CSL Behring Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. CSL Behring Hemostatic Agents and Tissue Sealants Product
Table 114. CSL Behring Recent Developments/Updates
Table 115. CryoLife Corporation Information
Table 116. CryoLife Description and Business Overview
Table 117. CryoLife Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. CryoLife Hemostatic Agents and Tissue Sealants Product
Table 119. CryoLife Recent Developments/Updates
Table 120. Zimmer Biomet Corporation Information
Table 121. Zimmer Biomet Description and Business Overview
Table 122. Zimmer Biomet Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Zimmer Biomet Hemostatic Agents and Tissue Sealants Product
Table 124. Zimmer Biomet Recent Developments/Updates
Table 125. Ferrosan Medical Devices Corporation Information
Table 126. Ferrosan Medical Devices Description and Business Overview
Table 127. Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Product
Table 129. Ferrosan Medical Devices Recent Developments/Updates
Table 130. Medtronic Corporation Information
Table 131. Medtronic Description and Business Overview
Table 132. Medtronic Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Medtronic Hemostatic Agents and Tissue Sealants Product
Table 134. Medtronic Recent Developments/Updates
Table 135. Smith & Nephew Corporation Information
Table 136. Smith & Nephew Description and Business Overview
Table 137. Smith & Nephew Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Smith & Nephew Hemostatic Agents and Tissue Sealants Product
Table 139. Smith & Nephew Recent Developments/Updates
Table 140. Z-Medica Corporation Information
Table 141. Z-Medica Description and Business Overview
Table 142. Z-Medica Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Z-Medica Hemostatic Agents and Tissue Sealants Product
Table 144. Z-Medica Recent Developments/Updates
Table 145. Cohera Medical Corporation Information
Table 146. Cohera Medical Description and Business Overview
Table 147. Cohera Medical Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Cohera Medical Hemostatic Agents and Tissue Sealants Product
Table 149. Cohera Medical Recent Developments/Updates
Table 150. Marine Polymer Corporation Information
Table 151. Marine Polymer Description and Business Overview
Table 152. Marine Polymer Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Marine Polymer Hemostatic Agents and Tissue Sealants Product
Table 154. Marine Polymer Recent Developments/Updates
Table 155. Equimedical Corporation Information
Table 156. Equimedical Description and Business Overview
Table 157. Equimedical Hemostatic Agents and Tissue Sealants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Equimedical Hemostatic Agents and Tissue Sealants Product
Table 159. Equimedical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Hemostatic Agents and Tissue Sealants Distributors List
Table 163. Hemostatic Agents and Tissue Sealants Customers List
Table 164. Hemostatic Agents and Tissue Sealants Market Trends
Table 165. Hemostatic Agents and Tissue Sealants Market Drivers
Table 166. Hemostatic Agents and Tissue Sealants Market Challenges
Table 167. Hemostatic Agents and Tissue Sealants Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hemostatic Agents and Tissue Sealants
Figure 2. Global Hemostatic Agents and Tissue Sealants Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hemostatic Agents and Tissue Sealants Market Share by Type in 2023 & 2030
Figure 4. Hemostasis Agents Product Picture
Figure 5. Tissue Sealing Agents Product Picture
Figure 6. Global Hemostatic Agents and Tissue Sealants Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hemostatic Agents and Tissue Sealants Market Share by Application in 2023 & 2030
Figure 8. Minimally Invasive Surgery
Figure 9. General Surgery
Figure 10. Others
Figure 11. Global Hemostatic Agents and Tissue Sealants Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Hemostatic Agents and Tissue Sealants Market Size (2019-2030) & (US$ Million)
Figure 13. Global Hemostatic Agents and Tissue Sealants Sales (2019-2030) & (K Units)
Figure 14. Global Hemostatic Agents and Tissue Sealants Average Price (US$/Unit) & (2019-2030)
Figure 15. Hemostatic Agents and Tissue Sealants Report Years Considered
Figure 16. Hemostatic Agents and Tissue Sealants Sales Share by Manufacturers in 2023
Figure 17. Global Hemostatic Agents and Tissue Sealants Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Hemostatic Agents and Tissue Sealants Players: Market Share by Revenue in 2023
Figure 19. Hemostatic Agents and Tissue Sealants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Hemostatic Agents and Tissue Sealants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Hemostatic Agents and Tissue Sealants Sales Market Share by Country (2019-2030)
Figure 22. North America Hemostatic Agents and Tissue Sealants Revenue Market Share by Country (2019-2030)
Figure 23. United States Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Hemostatic Agents and Tissue Sealants Sales Market Share by Country (2019-2030)
Figure 26. Europe Hemostatic Agents and Tissue Sealants Revenue Market Share by Country (2019-2030)
Figure 27. Germany Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Hemostatic Agents and Tissue Sealants Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Hemostatic Agents and Tissue Sealants Revenue Market Share by Region (2019-2030)
Figure 34. China Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Hemostatic Agents and Tissue Sealants Sales Market Share by Country (2019-2030)
Figure 44. Latin America Hemostatic Agents and Tissue Sealants Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Hemostatic Agents and Tissue Sealants Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Hemostatic Agents and Tissue Sealants Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Hemostatic Agents and Tissue Sealants Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Hemostatic Agents and Tissue Sealants by Type (2019-2030)
Figure 54. Global Revenue Market Share of Hemostatic Agents and Tissue Sealants by Type (2019-2030)
Figure 55. Global Hemostatic Agents and Tissue Sealants Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Hemostatic Agents and Tissue Sealants by Application (2019-2030)
Figure 57. Global Revenue Market Share of Hemostatic Agents and Tissue Sealants by Application (2019-2030)
Figure 58. Global Hemostatic Agents and Tissue Sealants Price (US$/Unit) by Application (2019-2030)
Figure 59. Hemostatic Agents and Tissue Sealants Value Chain
Figure 60. Hemostatic Agents and Tissue Sealants Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
